Kidney Research and Clinical Practice

Using the Mayo Imaging Classification to predict renal outcomes in Korean autosomal dominant polycystic kidney disease patients: Yeonsoon Jung; Kidney Res Clin Pract. 2022;41(4):389-392. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.22.016; Full text PubReader ePub Crossref - TDM PDF

Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia: Yeonhee Lee, Kyung Don Yoo, Seon Ha Baek et al.; Kidney Res Clin Pract. 2022;41(4):393-411. Published online July 28, 2022; DOI: https://doi.org/10.23876/j.krcp.33.555; Full text PubReader ePub Crossref - TDM PDF

Application of C5 inhibitors in glomerular diseases in 2021: Alexis Werion, Eric Rondeau; Kidney Res Clin Pract. 2022;41(4):412-421. Published online March 15, 2022; DOI: https://doi.org/10.23876/j.krcp.21.248; Full text PubReader ePub Crossref - TDM PDF

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309; Full text PubReader ePub Crossref - TDM PDF

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study: Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon et al.; Kidney Res Clin Pract. 2022;41(4):432-441. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.261; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population: Jin Ho Kwak, Jin Hyuk Paek, Gyeong Im Yu et al.; Kidney Res Clin Pract. 2022;41(4):442-451. Published online February 23, 2022; DOI: https://doi.org/10.23876/j.krcp.21.075; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

An intradialytic aerobic exercise program ameliorates frailty and improves dialysis adequacy and quality of life among hemodialysis patients: a randomized controlled trial: Sunki Kim, Hye-Ja Park, Dong-Ho Yang; Kidney Res Clin Pract. 2022;41(4):462-472. Published online March 31, 2022; DOI: https://doi.org/10.23876/j.krcp.21.284; Full text PubReader ePub Crossref - TDM PDF

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study: Suyun Jung, Hyosang Kim, Hyunwook Kwon et al.; Kidney Res Clin Pract. 2022;41(4):473-481. Published online February 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.210; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against chronic kidney disease patients: Maria Korogiannou, Marieta Theodorakopoulou, Pantelis Sarafidis et al.; Kidney Res Clin Pract. 2022;41(4):482-491. Published online June 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.250; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort: Hee Jung Jeon, Tai Yeon Koo, Man Ki Ju et al.; Kidney Res Clin Pract. 2022;41(4):492-507. Published online July 28, 2022; DOI: https://doi.org/10.23876/j.krcp.21.185; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy and safety of rapid intermittent bolus compared with slow continuous infusion in patients with severe hypernatremia (SALSA II trial): a study protocol for a randomized controlled trial: Ji Young Ryu, Songuk Yoon, Jeonghwan Lee et al.; Kidney Res Clin Pract. 2022;41(4):508-520. Published online April 13, 2022; DOI: https://doi.org/10.23876/j.krcp.21.193; Full text PubReader ePub Crossref - TDM PDF

3,040	Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia
3,221	Renal side effects of COVID-19 vaccines in patients with immunoglobulin A nephropathy
7,656	Pediatric acute kidney injury: new advances in the last decade
2,119	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
4,199	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)

Cited By 32	Mitochondrial dysfunction in kidney injury, inflammation, and disease: potential therapeutic approaches
Cited By 20	Diagnosis of renal transplant rejection: Banff classification and beyond
Cited By 20	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 19	The KNOW-CKD Study: What we have learned about chronic kidney diseases
Cited By 17	Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities

Previous issues